UCB SA (UCBJY)
150.83
+1.26
(+0.84%)
USD |
OTCM |
Oct 28, 16:00
UCB Market Cap : 57.52B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 57.52B |
| October 27, 2026 | 57.03B |
| October 26, 2026 | 57.45B |
| October 23, 2026 | 57.93B |
| October 22, 2026 | 55.18B |
| October 21, 2026 | 45.69B |
| October 20, 2026 | 46.64B |
| October 19, 2026 | 43.55B |
| October 16, 2026 | 43.65B |
| October 15, 2026 | 44.03B |
| October 14, 2026 | 42.94B |
| October 13, 2026 | 42.24B |
| October 12, 2026 | 43.46B |
| October 09, 2026 | 43.54B |
| October 08, 2026 | 43.35B |
| October 07, 2026 | 43.55B |
| October 06, 2026 | 43.28B |
| October 05, 2026 | 43.09B |
| October 02, 2026 | 43.94B |
| October 01, 2026 | 43.23B |
| September 30, 2026 | 44.23B |
| September 29, 2026 | 44.85B |
| September 28, 2026 | 46.20B |
| September 25, 2026 | 46.77B |
| September 24, 2026 | 46.02B |
| Date | Value |
|---|---|
| September 23, 2026 | 45.82B |
| September 22, 2026 | 46.45B |
| September 21, 2026 | 46.45B |
| September 18, 2026 | 45.60B |
| September 17, 2026 | 45.66B |
| September 16, 2026 | 45.03B |
| September 15, 2026 | 46.14B |
| September 14, 2026 | 46.30B |
| September 11, 2026 | 45.51B |
| September 10, 2026 | 44.64B |
| September 09, 2026 | 45.25B |
| September 08, 2026 | 45.78B |
| September 04, 2026 | 46.66B |
| September 03, 2026 | 49.03B |
| September 02, 2026 | 48.69B |
| September 01, 2026 | 48.13B |
| August 31, 2026 | 47.65B |
| August 28, 2026 | 47.77B |
| August 27, 2026 | 49.13B |
| August 26, 2026 | 49.00B |
| August 25, 2026 | 49.89B |
| August 24, 2026 | 49.00B |
| August 21, 2026 | 49.28B |
| August 20, 2026 | 48.09B |
| August 19, 2026 | 48.82B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.319T |
| AstraZeneca PLC | 543.01B |
| Corcept Therapeutics, Inc. | 9.379B |
| Jazz Pharmaceuticals Plc | 13.53B |
| Novo Nordisk A/S | 129.65B |
Market Cap Related Metrics
| PE Ratio | 22.88 |
| PS Ratio | 5.888 |
| PEG Ratio | 0.0256 |
| Price to Free Cash Flow | 41.59 |
| Price | 150.83 |
| Earnings Yield | 4.37% |
| PEGY Ratio | 0.0256 |
| Operating PE Ratio | 18.50 |
| Normalized PE Ratio | 22.68 |